Triple
T25664173
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Food and Drug Administration Safety and Innovation Act of 2012 |
E643466
|
entity |
| Predicate | hasComponent |
P35
|
FINISHED |
| Object |
Medical Device User Fee Amendments reauthorization
The Medical Device User Fee Amendments reauthorization is a U.S. law that renews and updates the FDA’s authority to collect user fees from medical device manufacturers in exchange for meeting performance goals in the device review process.
|
E1689553
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Medical Device User Fee Amendments reauthorization | Statement: [Food and Drug Administration Safety and Innovation Act of 2012, hasComponent, Medical Device User Fee Amendments reauthorization]
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Medical Device User Fee Amendments reauthorization Triple: [Food and Drug Administration Safety and Innovation Act of 2012, hasComponent, Medical Device User Fee Amendments reauthorization]
Generated description
The Medical Device User Fee Amendments reauthorization is a U.S. law that renews and updates the FDA’s authority to collect user fees from medical device manufacturers in exchange for meeting performance goals in the device review process.
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e77e7e45648190a068ed3faa8016ea |
completed | April 21, 2026, 1:41 p.m. |
| NER | Named-entity recognition | batch_69f5faf1f9c48190ad732234e836b143 |
completed | May 2, 2026, 1:24 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_6a10c152bcc48190bb544e464d848bf5 |
completed | May 22, 2026, 8:49 p.m. |
| NEDg | Description generation | batch_6a10c2d522988190bc01978dc5ef272f |
completed | May 22, 2026, 8:55 p.m. |
| NED2 | Entity disambiguation (via description) | batch_6a10c36b20a0819084d94066362937ee |
completed | May 22, 2026, 8:58 p.m. |
Created at: April 21, 2026, 6:59 p.m.